BEA-2180-BR

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBEA-2180-BR
Drug Alias NameBEA-2180BEA-2180-BR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A